https://www.prnewswire.com/news/syneron-medical-ltd./?page=2&pagesize=25
Syneron Medical Ltd. News and Press Releases | PR Newswire
news and press releasessyneron medical ltdnewswire
https://www.prnewswire.com/news-releases/syneron-medical-to-participate-in-leerink-partners-6th-annual-global-healthcare-conference-300406016.html
Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer,...
syneron medicalto participateleerink partners
https://www.fiercebiotech.com/biotech/four-months-after-100m-series-syneron-closes-150m-round-support-peptide-platform
Syneron closes $150M round to support peptide platform
Apr 3, 2026 - Peptide drug discovery company Syneron Bio closed a $150 million series B round to support its macrocyclic peptide development platform.
to supportsyneroncloses150mround
https://www.prnewswire.com/news/syneron-medical-ltd./?page=5&pagesize=25
Syneron Medical Ltd. News and Press Releases | PR Newswire
news and press releasessyneron medical ltdnewswire
https://www.biospace.com/syneron-medical-ltd-to-participate-in-the-b-barclays-b-global-healthcare-conference
Syneron Medical Ltd. To Participate In The Barclays Global Healthcare Conference - BioSpace
syneron medical ltdto participatein the
https://www.prnewswire.com/news-releases/syneron-candela-completes-previously-announced-transaction-with-funds-advised-by-apax-partners-and-becomes-a-private-company-300488934.html
Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and...
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, today announced the successful completion of its...
https://www.prnewswire.com/news-releases/syneron-medical-reports-first-quarter-2016-revenue-of-687-million-300271591.html
Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period...
syneron medicalfirst quarterreports
https://www.prnewswire.com/news-releases/syneron-medical-and-allergan-announce-us-aesthetics-collaboration-300231427.html
Syneron Medical and Allergan Announce U.S. Aesthetics Collaboration
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS) a leading global aesthetic device company, and Allergan plc, (NYSE: AGN) a leading global pharmaceutical...
syneron medicalallerganannounceaestheticscollaboration
https://www.prnewswire.com/news-releases/syneron-medical-reports-third-quarter-2016-revenue-of-715-million-300359721.html
Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced financial results for the three month period...
syneron medicalthird quarterreports
https://www.prnewswire.com/news-releases/syneron-medical-to-report-fourth-quarter-2015-and-full-year-2015-financial-results-on-february-22-2016-300214791.html
Syneron Medical to Report Fourth Quarter 2015 and Full Year 2015 Financial Results on February 22,...
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2015 and...
https://www.prnewswire.com/news-releases/syneron-medical-to-report-first-quarter-2016-financial-results-on-may-19-2016-300258355.html
Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2016...
syneron medicalfirst quarter
https://www.biospace.com/syneron-medical-ltd-expands-management-team
Syneron Medical Ltd. Expands Management Team - BioSpace
syneron medical ltdmanagement teamexpands
https://www.prnewswire.com/news-releases/syneron-candela-announces-fda-clearance-of-high-energy-ultrashape-power-for-fat-destruction-300299830.html
Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA)...
https://www.prnewswire.com/news/syneron-medical-ltd./?page=4&pagesize=25
Syneron Medical Ltd. News and Press Releases | PR Newswire
news and press releasessyneron medical ltdnewswire
https://www.prnewswire.com/news-releases/syneron-medical-ltd-announces-availability-of-its-annual-report-on-form-20-f-through-its-website-300239011.html
Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website
/PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F,...